The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.
Study Type
OBSERVATIONAL
Enrollment
580
Endovascular treatment for patients with primary and secondary liver tumors
IRCCS Ospedale San Raffaele
Milan, Italy
RECRUITINGProgression free survival
Treatment Efficacy
Time frame: Short term (3-6 months)
Progression free survival
Time frame: From time of intervention up to 1 year (medium term)
Progression free survival
Time frame: From time of intervention up to 5 years (Long term)
Residual hepatic volume
Treatment Efficacy
Time frame: within 40 days of procedure
Overall survival
Overall survival
Time frame: From date of procedure until the date of death from any cause, whichever came first, assessed up to 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.